About the Author(s)


Ammaarah Sheik Adam Email symbol
Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

Frasia Oosthuizen symbol
Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

Varsha Bangalee symbol
Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

Citation


Adam AS, Oosthuizen F, Bangalee V. An assessment of traditional and complementary medicine utilisation in cancer patients from KwaZulu-Natal, South Africa: A cross-sectional study. S. Afr. j. oncol. 2026; 10(0), a371. https://doi.org/10.4102/sajo.v10i0.371

Note: Additional supporting information may be found in the online version of this article as Online Appendix 1 and Online Appendix 2.

Original Research

An assessment of traditional and complementary medicine utilisation in cancer patients from KwaZulu-Natal, South Africa: A cross-sectional study

Ammaarah Sheik Adam, Frasia Oosthuizen, Varsha Bangalee

Received: 29 Jan. 2026; Accepted: 13 May 2026; Published: 21 July 2026

Copyright: © 2026. The Author(s). Licensee: AOSIS.
This work is licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license (https://creativecommons.org/licenses/by/4.0/).

Abstract

Background: Traditional and complementary medicine (T&CM) use among cancer patients is increasing globally; however, it remains under-researched. Anticancer drugs have a narrow therapeutic window, and the use of complementary products may interact with chemotherapy.

Aim: This study aims to investigate the prevalence of T&CM usage, reasons for use, perceived value of T&CM and patient disclosure of T&CM use to physicians among cancer patients in KwaZulu-Natal, South Africa.

Setting: Surveys were conducted at oncology centres in the private sector in KwaZulu-Natal.

Methods: Adult cancer patients were approached to complete a survey collecting demographic data and information related to the use of T&CM. An adapted version of the International Complementary and Alternative Medicine Questionnaire was used.

Results: Sixty-nine per cent of the 100 patients surveyed were T&CM users, of which, 57% used at least one form of T&CM to treat either a side effect of chemotherapy, cancer symptoms or cancer itself. Vitamins and/or minerals were used by 45% of participants, 27% used herbal products and 9% used homeopathic remedies. The most common self-help practice was prayer (77%). One-third of T&CM users disclosed their T&CM use to their physician.

Conclusion: Most cancer patients rely on mainstream conventional medicine to treat cancer itself. However, many still use T&CM, and it is an important consideration when patients are undergoing chemotherapy. A relatively low percentage of patients disclosed T&CM use.

Contribution: This study provides recent data on commonly used T&CM modalities, reasons for use and perceived benefits. These findings emphasise potential safety considerations and the need for more integrative T&CM discussions with patients.

Keywords: traditional medicine; complementary medicine; alternate medicine; herbal medicine; cancer patients; patient disclosure.

Introduction

For the year 2021, World Health Organization (WHO) Global Data revealed cancer to be the second leading cause of death worldwide. In 2020, 10 million deaths were attributed to cancer, of which 70% was from low- and middle-income countries (LMICs).1

As defined by the WHO,2 complementary medicine (CM) is a collection of healthcare practices falling outside conventional medicine and are not entirely incorporated into the mainstream healthcare system. The WHO states traditional medicine (TM) refers to the knowledge, skills and practices from indigenous theories, beliefs and experiences of different cultures being used to maintain health, and prevent, diagnose, improve or treat physical and mental illness.2 The WHO further merges both terms to create traditional and complementary medicine (T&CM), which includes products, practices and practitioners.2

The WHO Global Traditional Medicine Strategy 2025–2034 gave the first formal definition of integrative medicine, describing it as an evidence-informed, interdisciplinary approach that combines biomedical knowledge with T&CM practices to support health and well-being.3 The strategy emphasises strengthening scientific evidence and regulatory frameworks to ensure the safe and appropriate integration of Traditional, Complementary, and Integrative Medicine (TCIM) into health systems.3 Its overarching goal is to promote universal access to safe, effective, and patient-centred TCIM, balancing scientific evidence with cultural respect while protecting biodiversity and indigenous knowledge.3

Average T&CM use in Africa is estimated to be 58.2% and has been widely used for many years to maintain health or prevent and treat infectious and non-communicable diseases.4,5,6 Traditional and complementary medicine practices vary significantly across the globe, and even within countries, due to several factors such as diverse cultural beliefs, historical significance and the availability, affordability and accessibility of T&CM.7 In South Africa, traditional herbal medicine was found to be very popular for treating human immunodeficiency virus (HIV),8 and some also use herbal medicine for chronic conditions such as hypertension9 and type 2 diabetes.10 Traditional and complementary medicine has been adopted by South Africans to prevent and treat acute illnesses, such as headaches, the flu and common cold, indigestion and stomach problems.11 Homoeopathy and massage therapy were found to be popular T&CM modalities reported by South Africans.12

In South Africa, the yearly prevalence of T&CM was reported to be 24% among the adult population.13 In 2010, the Allied Health Professions Council of South Africa (AHPCSA) recognised and registered the following treatment modalities that were found to be common among the South African population: Acupuncture, aromatherapy, chiropractic, herbal medicines, homeopathy, massage therapy, naturopathy, osteopathy, therapeutic reflexology, traditional Chinese medicine and traditional Indian medicine such as Ayurveda and Unani.14 Despite T&CM being popular in South Africa, the incorporation of T&CM into the mainstream healthcare system remains a challenge due to the lack of scientific research and documented safety and effectiveness of T&CM.14

Traditional medicine products in South Africa (known as muthi) often incorporate the use of animal, plant and mineral-based products, while TM practices include communicating with ancestors and ritualistic activities.15 Most treatment forms are made from plant-derived products that are indigenous to South Africa.15 Some of the most popular medicinal plants include buchu, African potato, African wormwood, honeybush, devil’s claw, fever tea, pepperbark tree, cancer bush and milk bush.15 Commonly sought TM practitioners in South Africa include diviners called iSangoma, spiritual healers who receive callings called Umthandazis and herbalists called iNyanga.16 Traditional health practitioners also include traditional surgeons and traditional birth attendants.17

South Africa has a two-tiered healthcare system consisting of a public and private sector.18 The public sector is funded by general taxation, and private healthcare is paid for out-of-pocket, often via monthly contributions to medical aid schemes. In South Africa, T&CM is paid for out-of-pocket as it primarily falls within the private healthcare sector. Additionally, while a few medical aid schemes might cover selected T&CM modalities, it is not fully covered, and individuals carry the bulk of the expenses.18 Findings from a South African study revealed 73% of participants reported spending less than R100.00 per month on traditional herbal medicines, while a further 17% spent under R250.00 per month.19

A systematic review, conducted by James et al. in 2018,20 found that most patients using T&CM do not disclose their use to physicians, either because their doctors did not ask about T&CM use or the patient fears retribution. When it comes to anticancer drugs, most have a very narrow therapeutic window, and the use of herbal supplements, which cancer patients may perceive as harmless, could interact with a chemotherapy regimen, reducing its efficacy or enhancing its toxic effects.21 There is thus a need to assess the prevalence of T&CM use in cancer patients and determine how many cancer patients discuss T&CM with their physicians. An integrated approach of CM and conventional cancer care could increase patient satisfaction and quality of life, while monitoring the effects, risks and interactions between T&CM and conventional chemotherapy.

This study aims to investigate the prevalence of T&CM usage, reasons for use and perceived value of T&CM among cancer patients attending oncology centres in the private sector in KwaZulu-Natal, South Africa. This study will also evaluate if patients discuss T&CM use with their physician.

Methods

Study design and setting

A cross-sectional, descriptive study was carried out to describe the use of traditional, complementary and alternative medicine among cancer patients. The study setting included two oncology centres within the private healthcare sector located in the KwaZulu-Natal province of South Africa. A total of five private sector healthcare groups known to manage substantial numbers of cancer patients in KwaZulu-Natal were approached for permission to conduct this study within their facilities. Of these, only one group granted consent, authorising data collection at two of its oncology units in the province. Study participants included adult cancer patients attending the oncology centres from January 2024 to July 2024 for cancer treatment or to visit their oncologist.

Study target population and sampling strategy

The target population was adult cancer patients who were receiving conventional cancer treatment. Purposive sampling was used as participants needed to be selected based on a criterion of characteristics.

The following inclusion criteria applied:

  • Persons above the age of 18 years.
  • A diagnosis of cancer.
  • Receiving conventional therapy and/or seeing a physician regarding their cancer.

The following exclusion criteria applied:

  • Persons under the age of 18 years.
  • No cancer diagnoses or new cancer diagnosis (diagnosis received within 3 months).
  • Patients refusing to give informed consent.

All patients who were seriously ill and in distress or pain were excluded.

A total of 100 cancer patients met the inclusion criteria, making it a suitable sample size. The minimum sample size was set to be 96 participants. This sample size was determined using the Creative Research Systems sample size calculator.22 The confidence level was selected at 95%, the confidence interval chosen was 10, and the population box was left blank. Instructions on the survey system stipulate that the population box is to be left blank if the population is very large. Since it was unlikely that all patients approached will give consent and complete the questionnaire, oversampling (sampling more than 96 individuals) was used in order to ensure the minimum count was met.

Data collection

The data were collected through self-completed questionnaires. Patients interested in participating were given the consent form and questionnaire to complete (Online Appendix 1).

The questionnaire was made up of two parts: one collected demographic information, and the other collected information related to the use of T&CM. The demographic data included gender, age, race, religion, education, employment, income and medical information. The questions pertaining to T&CM collected data on the types of T&CM used, reasons for use and perceived satisfaction with T&CM, as well as whether cancer patients discussed T&CM use with their physician. The survey used in the study is based on the previously validated International Complementary and Alternative Medicine Questionnaire (I-CAM-Q).23 The consent form and questionnaire were prepared in English only, and it was ensured that all participants had sufficient English proficiency and did not require a translator. The adapted questionnaire was pretested among 15 cancer patients at the oncology centre in KwaZulu-Natal. The questions were well interpreted and answered without assistance; thus, no modification was necessary.

Data analysis

Complementary medicines were analysed from the six major disciplines recognised by the South African Health Products Regulatory Authority (SAHPRA): Aromatherapy, Ayurveda, Homeopathy, traditional Chinese Medicine, Unani Tibb and Western Herbal Medicine.24 South African Health Products Regulatory Authority also categorises combination products, such as health supplements, as CM – ‘health supplements’ refers to any substance, extract or mixture of substances that is purportedly used to restore, correct or modify any physical or mental state by complementing health; supplementing the diet; or a nutritional effect, and excludes injectables and medicines listed as Schedule 1 or higher.24 This criterion was used to classify which products used by cancer patients fall within the T&CM categories.

A cancer patient was considered to be a T&CM user if they answered ‘yes’ to using at least one of the following products or practices: Manipulation techniques (chiropractic or osteopathic treatment), acupuncture, Reiki, reflexology, homeopathic remedies, vitamins and/or minerals, TMs or herbal products. This study also evaluated the prevalence of prayer and self-help practices such as meditation, yoga and relaxation techniques to increase comparability with other studies. Physiotherapy does complement anticancer treatment; however, it does not form part of T&CM, thus results were reported separately. Seeing healthcare professionals that form part of mainstream medicine, such as physiotherapists and psychologists, were included to gauge the number of participants who may prefer mainstream treatment over T&CM.

Data were analysed using descriptive statistics, and responses were presented in the form of frequency tables. Logistic regression analysis was conducted to determine if there are any variables that can predict T&CM use among participants. Any misleading information and biased representation of data were avoided – data were categorised and recorded as answered by the participants. The analyses and discussions were conducted with a focus on rigour and continuous reflection to minimise potential bias. The STROBE cross-sectional guidelines were used when reporting results of the study (Online Appendix 2).25

Data confidentiality and ethical approval

To maintain confidentiality and anonymity of the individuals participating in the study, no patient names have been reported, and the name of oncology centres is not disclosed. The voluntary participation of cancer patients in this research was important; hence, written informed consent was obtained from every participant. The consent form was separated from the questionnaire so identities could not be linked to responses.

Ethical considerations

Ethical approval for this study was obtained from the Biomedical Research and Ethics Committee (BREC) at the University of KwaZulu-Natal (UKZN). Reference number: BREC/00005784/2023. Permission to conduct this study at the premises was approved by the relevant private sector group. Reference number: CRIP-12042023/09. Written informed consent was obtained from all cancer participants prior to them receiving the survey.

Results

Sociodemographic characteristics of the study

The final study sample consisted of 100 adult cancer patients. One hundred and thirty-four people were approached and informed about the study, of which 34 individuals declined participation in the study, resulting in a response rate of 74.6%. Sociodemographic data of the study sample is presented in Table 1. More than half of the patients surveyed were females (59%). Most of the respondents belonged in the 45–54 years age group (30%), followed by the 55–64 years age group (28%). Out of the 100 patients surveyed, the majority (47%) were Indian people, with the main religion being Christianity (46%). The study sample consisted mostly of fulltime employed participants (45%), those with a middle-income level (38%) and those having received a tertiary education (52%).

TABLE 1: The sociodemographic characteristics of the sample (N = 100).
Medical information and traditional and complementary medicine familiarity

In the past 12 months, all patients surveyed saw their physician regarding their cancer diagnosis and received conventional cancer treatment. Sixty-seven per cent of participants stated they were familiar with T&CM, 47% were interested in learning more about T&CM therapies and 28% of patients used T&CM before receiving their cancer diagnosis.

Prevalence of traditional and complementary medicine use

It was found that 69% of the patients surveyed were T&CM users. When the reason for T&CM use was evaluated, 57 patients used at least one form of T&CM to treat either a side effect of chemotherapy, cancer symptoms or cancer itself. The logistic regression analysis conducted to determine if any sociodemographic factors can predict T&CM use among participants revealed that no significant predictors were observed (no p < 0.05). Table 2 provides the results from the logistic regression model.

TABLE 2: Results from logistic regression used to examine predictors of traditional and complementary medicine use.
Different healthcare providers sought by cancer patients

Cancer patients were surveyed to assess types of healthcare providers consulted, reasons for seeking care and perceived helpfulness. The most sought provider was physicians (commonly referred to as medical doctors or general practitioners) by 78% of participants. Thirty-two cancer patients visited physicians to treat cancer itself, of which 27 patients found them very helpful. A total of 69 cancer patients saw a physiotherapist and 58 stated they were very helpful. Most cancer patients go for physiotherapy to improve well-being (n = 22), treat cancer symptoms (n = 17), or treat an illness not related to cancer (n = 10). Sixteen participants sought acupuncturists, and 15 participants visited a chiropractor. Other healthcare providers included herbalists, homeopaths, psychologists, Reiki healers and reflexologists. Table 3 details the number of cancer patients visiting different healthcare providers and for what reasons.

TABLE 3: Number of cancer patients who visited healthcare providers, main reason for visiting and reported satisfaction (N = 100).
Traditional and complementary medicine recommended or offered by physicians

Twenty-one participants reported that their physician recommended either physiotherapy or manipulation techniques. Seventeen cancer patients took their physician’s advice and saw a physiotherapist, resulting in 13 patients finding physiotherapy very helpful. Manipulation therapy was used by four participants to improve well-being or treat an illness not related to cancer. Table 4 summarises participant responses regarding therapies recommended by their physician.

TABLE 4: Traditional and complementary medicine offered or recommended by physicians (N = 100).
Use of herbal medicine and dietary supplements

Cancer patients were asked to categorise and write down the products they currently use alongside chemotherapy. Vitamins and/or minerals were used by 45 participants, 27 participants stated they used herbal products, nine participants used homeopathic remedies, and four participants made use of other products. Table 5 contains the names of the products used, the main reason why the participant used it and how helpful they perceived the product to be. Multivitamins were taken by 14% of the total participants. Several patients made use of herbal products such as Moringa (n = 6), African Herbal Medicine (n = 4) and medicated castor oil (n = 2).

TABLE 5: Traditional and complementary medicine products used, main reason for use and reported satisfaction.
Self-help practices

The most used practice by patients was prayer. Seventy-seven cancer patients prayed for their health, of which, 61 found it very helpful. If prayer is considered a T&CM practice, then T&CM use would increase to 94%. Meditation and relaxation techniques were mostly used to improve well-being. Yoga was performed by 23 participants, of which 16 found it to be very helpful. Table 6 summarises participant responses to self-help practices. Other practices used by cancer patients include visualisation (n = 3), Pilates (n = 3), massage therapy (n = 2), aromatherapy (n = 1), attending a support group (n = 1), swimming (n = 1) and exercise (n = 1).

TABLE 6: Self-help practices used, reasons for use and reported satisfaction.
Disclosure of traditional and complementary medicine to physicians

A total of 23 participants informed their physician about T&CM use, thus making the disclosure rate 33.3%. When evaluating who first brought up the topic of T&CM, it was found that patients initiated the conversation in 52% of situations. The most common reasons for patients to tell their physician were either because they believed their physician should know, or patients wanted more information about T&CM. Table 7 and Table 8 detail the number of patients and the reason why they told or did not tell their physician about T&CM use. The most common reason why cancer patients did not tell their physician was simply because their physician did not ask about T&CM.

TABLE 7: Reasons why cancer patients informed physicians about traditional and complementary medicine use.
TABLE 8: Reasons why cancer patients did not inform physicians about traditional and complementary medicine use.

Discussion

Prevalence of traditional and complementary medicine use

Recent data from full-text articles published in English regarding T&CM use in cancer patients were available for the following sub-Saharan African countries: Ethiopia, Ghana, Kenya, Malawi, Morocco, Nigeria, Tanzania and Uganda over a 10-year period (from 01 January 2013 to 31 December 2022). From the articles found, T&CM use in sub-Saharan Africa ranged from 14.1% to 84% with an average of 66.7% of cancer patients using T&CM. The prevalence of T&CM ranges from 30% to 60% in high-income countries (HICs)26 and 40% – 70% in LMICs.27 Findings from a thesis of a descriptive cross-sectional study conducted at an academic hospital in Johannesburg, involving 120 participants, indicated that 33% of respondents reported using complementary and alternative medicines.28 This cross-sectional study conducted within the private sector in KwaZulu-Natal, South Africa, revealed that 69% of cancer patients surveyed were T&CM users, similar to the findings of other regions in sub-Saharan Africa.

This study achieved its primary aim of determining the prevalence of T&CM use. The most used T&CM products were vitamins, minerals and herbal medicines, the most visited T&CM providers were acupuncturists and chiropractors, and the most used practices included meditation and prayer. Details on the reasons for use and perceived value of T&CM are further explored according to the main modality categories, namely vitamins and minerals, herbal medicine, acupuncture, chiropractic therapy, homeopathy, osteopathic manipulation therapy, Reiki, reflexology, faith-based practices, meditation, relaxation and yoga.

Vitamins and minerals

This study revealed 45% of cancer patients took at least one type of vitamin and/or mineral supplement, and the most common main reason for taking it was to improve well-being followed by hoping it would help treat a symptom of cancer. Within sub-Saharan Africa, the use of vitamin and mineral supplements among cancer patients was found to be 55.1% in Ghana,29 22.1% in Ethiopia,30 23% in Malawi31 and 13.8% in Uganda.32 The use of vitamins and/or minerals in HICs ranges from approximately 40% to 80%33 and in LMICs ranges from 30% to 60% within oncology populations.33,34 Vitamin and mineral supplementation is a common practice among cancer patients across the globe, and its use to improve well-being emphasises its role as an adjunct to conventional cancer treatment.

Vitamins refer to a group of substances required in small amounts for healthy growth and development.35 Minerals are elements found on earth and in foods that is needed by our bodies in small amounts to develop and function normally.35 The most common reason why patients took a vitamin or mineral supplement was to improve general well-being; however, some supplements may reduce the effectiveness of chemotherapy and radiation therapy. Many conventional anticancer treatments elicit their effect by creating free radicals that destroy the cancer cells, while some supplements may counteract the oxygen-free radicals, thus protecting cancer cells.36 For example, antioxidant supplements (such as vitamins A, C and E) may be associated with an increased rate of cancer recurrence.36 It is therefore important to be aware of possible interactions and for patients to be transparent about supplement use with their oncologists and allied healthcare professionals.

Herbal medicine

This study revealed 27% of participants used at least one type of herbal product. The most common products used were Moringa and African herbal medicine to improve overall well-being. Additionally, only eight cancer patients saw a herbalist with the reasons being to improve well-being and treat symptoms of cancer. The prevalence of herbal medicine use among the cancer population in sub-Saharan Africa was found to be 59.2% in Ghana,29 72.1% in Ethiopia,30 65% in Nigeria,37 56% in Malawi,31 70% in Tanzania,38 39% in Morocco,39 22% in Uganda32 and 91% in Kenya.40 The overall estimated average use of herbal medicine among cancer patients was found to be higher in LMICs with 32% compared to 17% in HICs.41

Six cancer patients from this study reported using Moringa. Potent antitumour activity was found in ethanolic extracts of the seed and leaves of Moringa oleifera due to 3 known thiocarbamate- and isothiocyanate-related compounds acting as tumour inhibitors.42 However, when evaluating the anticancer effect of Moringa seed extracts with chemotherapy in immunocompromised mice with triple negative breast cancer, it was found to worsen tumour progression.43 Medicated castor oil and aloe vera were used by patients to treat symptoms of cancer, and patient satisfaction was high. Aloe species are commonly used as a laxative and for treating skin-related conditions. Antimicrobial and anti-inflammatory properties of some aloe species have been shown, supporting their use as a form of T&CM.44 Despite limited research, aloe vera has shown effectiveness in fading post-chemotherapy-induced hyperpigmentation.45 One cancer patient made a mixture of almonds, sesame seeds, flax seeds, fennel, saffron and cardamom to help treat side effects of cancer. The main active ingredient in sesame seeds is Sesamin, and several studies revealed it possesses anticancer properties due its antiproliferative, pro-apoptotic, anti-inflammatory, antimetastatic and pro-autophagocytic activities.46 Research revealed that flaxseed consumption may help reduce one’s risk of cancer, diabetes, gastrointestinal disorders, heart disease and kidney disease.47 Studies have shown saffron possesses anticancer properties and can interfere with cancer-promoting signalling pathways.48 Research conducted found fennel inhibited the growth of some lung and colon cancer cell lines.49 Cardamom may complement conventional cancer treatment as it has antiproliferative and antimicrobial properties.50 Despite the benefits of herbal treatment, it is important to remember that herbal medicines used simultaneously with conventional drugs may result in potentially harmful herb–drug interactions.51

Acupuncture

In this study, acupuncture was used by 16% of patients, mostly for illnesses not related to cancer and to improve well-being. A few patients did see an acupuncturist to treat side effects of chemotherapy, treat cancer and cancer symptoms. Patient satisfaction with acupuncture was mixed; however, more than half of them stated that acupuncture was very helpful. From a study conducted in Uganda, it was found 3.3% of cancer patients saw an acupuncturist.32 Acupuncture was found to be more common in HICs compared to LMICs, and least common in African countries, which tend to rely more on TM systems rather than East Asian therapies.52,53

Acupuncture involves fine, sterile needles being inserted into the skin at specific points on the body. It is often used to relieve symptoms of physical and psychological conditions, including chronic pain.35 Evidence from a systematic review focusing on the effectiveness of acupuncture among cancer patients showed positive effects on cancer-related fatigue, nausea, vomiting and leucopoenia.54 However, there was inconsistent evidence supporting its ability to treat cancer-related pain, hot flashes, hiccups, and enhance overall quality of life.54

These findings suggest that acupuncture use among cancer patients remain relatively low and is sought mostly for symptomatic management and general well-being rather than direct cancer treatment.

Chiropractic therapy

A total of 15 participants from this study saw a chiropractor for illnesses not related to cancer, to improve well-being, or to treat a symptom of cancer, and most participants found them very helpful. The use of chiropractic care in HICs was found to be significant, especially for treating musculoskeletal pain, while prevalence was seen less among African, Hispanic and Asian populations.55 Chiropractic therapy involves a chiropractor using their hands to manipulate the spine and/or other parts of the body, most commonly to treat back and neck pain, or to improve overall health.56 From a study conducted among chiropractors, everyone agreed that cancer patients can benefit from chiropractic care.57 From experience with cancer patients, chiropractors reported helping patients with pain relief, mobility and improving quality of life.57 Chiropractic therapy is widely used, with over 900 registered practitioners in South Africa.58

Homeopathy

In this cross-sectional study, 8% of participants saw a homeopath while 9% used a homeopathic remedy. Most cancer patients used a homeopathic remedy to improve well-being, treat a symptom of cancer, or treat cancer itself. Homoeopathy is a therapy based on the theory that ‘like cures like’, conditions are treated using tiny doses of substances diluted several times so that it is indistinguishable from pure water and is activated by shaking called succession.35 Generally, there are no direct adverse effects or interactions between pharmaceutical agents and sufficiently diluted homeopathic remedies.59 The use of homeopathy among the cancer population varies across settings, with relatively higher prevalence in HICs (ranging from approximately 5% to 20%) compared to LMICs.60 However, empirical data have revealed that homeopathy is growing in popularity among adult patients and becoming more recognised as a treatment option in developing countries such as South Africa.61

In vitro and in vivo animal studies of homeopathic remedies have shown effectiveness in reducing cancer-cell viability and proliferation by targeting mitochondrial activity, increasing the generation of reactive oxygen species, and affecting cell membranes.62 These treatments can also trigger cytochrome-c release, leading to stress on cancer cells and apoptosis.62 Castor oil was used by one patient in this study to treat symptoms of cancer, and they found it somewhat helpful. Castor oil is commonly known and used for its laxative effect to treat constipation, and its anti-inflammatory effect to treat minor pains.63 Studies conducted in vitro and in vivo demonstrated that castor oil has anti-inflammatory, antioxidant, pain-inhibiting, cytotoxic, and antimicrobial effects; however, no human studies prove that castor oil has any anticancer effects.64 In this study, Salvestrol and curcumin remedies were used with the belief that it could cure cancer. Salvestrols are natural compounds found in various plants that can be safely consumed by humans. Within cancer cells, they undergo selective activation by the enzyme CYP1B1, which then inhibits cancer cell growth or causes cell death.65 Curcumin affects many cancer-related pathways and has shown in vitro effectiveness in treating several types of cancer, both alone and coupled with other chemotherapeutic agents.66 It has been found that curcumin can also inhibit some chemotherapy-induced side effects, for example, when it is given with cisplatin, curcumin increases the concentration of the enzyme responsible for hepatoprotection,67 and it can reduce nephrotoxicity via the downregulation of creatinine expression,68 thereby substantiating its use as a form of T&CM.

Osteopathic manipulation treatment

This study found 4% of cancer participants sought manipulation techniques to improve overall well-being or for reasons not related to cancer. Osteopathy was found to be used by 7.8% of participants in Portugal,69 2% of participants in Canada70 and 4.1% of participants in Norway.71 Osteopathy is increasingly being used as a supportive care tool for cancer patients in HICs, in contrast to LMICs, where prevalence is less common and access to regulated osteopathic care is limited.72

Manipulation is the use of hands to produce desired movement or a therapeutic effect in one or more parts of the patient’s body.35 Osteopathic manipulation treatment (OMT) improves circulation, relieves pain and helps correct structural imbalances by using the body’s natural self-healing abilities.73 Through focusing on the anatomic and physiologic basis of cancer symptoms, osteopathic manipulation can be a useful nonpharmacological technique to assist cancer patients reduce musculoskeletal pain, headaches,74 nausea and vomiting75 and constipation.76

Reiki

This study found 3% of participants used Reiki as a form of T&CM to improve well-being or treat a symptom of cancer. A Canadian study also revealed that 3% of their cancer participants saw a Reiki healer.70 Based on limited research, the prevalence of Reiki in a given population is estimated to be between 5% and 10%.77 Reiki is a type of alternative medicine that originated in Japan. Reiki involves a therapist placing their hands on or very close to a patient to boost their natural energy fields.35 Reiki is slowly becoming more popular among the South African population, and the Reiki Association of Southern Africa, founded in 2001, grew from eight members to over 1600 registered Reiki Practitioners.78 In a study conducted among private sector cancer patients, Reiki was reported to significantly reduce pain, fatigue, anxiety and depression.79

Reflexology

Only one participant in the cross-sectional study reported seeing a reflexologist to improve well-being and treat symptoms of cancer. From a Ugandan study, it was reported 3.8% of cancer patients used reflexology.32 Reflexology has been reported to be more commonly utilised in HICs, particularly popular in Norway, Denmark and the United Kingdom.80 Reflexology is based on the theory that reflex points on the feet correspond with all body parts. The thumb or fingers are used to apply pressure to the relevant reflex points in order to help with specific illnesses and/or restore the body’s natural balance and harmony.35 Reflexology offered to cancer patients resulted in a positive outcome for pain reduction, pain regulation and anxiety.81 A study conducted among breast cancer patients revealed reflexology was able to reduce some side effects of chemotherapy and cancer-related symptoms, thus increasing their quality of life.82

Self-help practices

Research has shown regular self-help and self-care practices during cancer treatment can reduce stress, anxiety and sleep disturbances.83 This study revealed 90% of participants used a self-help practice mostly to improve overall well-being. Self-help practices commonly employed are further discussed in detail below.

Faith-based practices

Faith-based practices were widely favoured, and high patient satisfaction was reported. From participants who saw a spiritual healer, attended traditional ceremonies and/or prayed for their own health, 80% stated they found it very helpful. These findings are similar to those of Chui et al. in 2014, where the most popular complementary practice among cancer patients was praying for their health (88.6%), and despite prayer not having the medical ability to cure a patient, prayer invokes a relaxation response and helps one maintain a positive and hopeful attitude.84 A study evaluating T&CM use in HIV patients in KwaZulu-Natal revealed prayer was popular among patients, especially to relieve stress, improve well-being and relieve pain.85 The use of faith-based practices was found to be highest in African settings, where average estimates suggest that 50% – 90% of patients engage in spiritual healing, which often coincides with TM and cultural belief systems.41 In LMICs, the prevalence remains high (approximately between 30% and 70%), while the use of faith healing in HICs is generally lower (estimated between 20% and 60%).41,86,87

Meditation

This study showed 48% of participants meditated and reported good satisfaction with the practice. The main reason participants meditated was to improve well-being, and a few patients reported meditating to help treat symptoms of cancer. Comparable studies using the I-CAM-Q among cancer patients found that 16% of cancer patients in Germany,88 15.7% of patients in Portugal,69 6.5% of participants in Canada,70 41.2% of participants in Poland89 and 29.1% of patients in Norway meditated.71 Research has shown meditation helps address stress, anxiety, fatigue, sleep disturbances and the general mood of cancer patients.90 These findings suggest that meditation is mostly adopted by cancer patients as a supportive strategy to enhance well-being and quality of life.

Relaxation techniques

From the study sample, 32% of participants stated they used relaxation techniques. Most patients used relaxation techniques to improve well-being or treat a symptom of cancer and reported high satisfaction. Other I-CAM-Q studies found that relaxation techniques were reported by 20% of participants in Germany,88 13.7% of participants in Portugal,69 8.5% of participants in Canada70 and 49.6% of participants in Poland.89 In Norway, 48.7% of cancer patients reported using relaxation techniques, and the most common reasons stated were to treat side effects of cancer or cancer treatment (33.8%), to strengthen the body or immune system (36.6%) and to increase quality of life or improve well-being (93.9%).71 In a study conducted among breast cancer patients undergoing chemotherapy, daily relaxation techniques revealed a statistically significant decrease in anxiety and fatigue levels, while alleviating symptoms of depression and distress.91

Yoga

Yoga was reported by 23% of cancer patients in this study to improve well-being, treat a symptom of cancer and to treat a side effect of chemotherapy. All patients who practised yoga reported good satisfaction. In Uganda, 2.7% of cancer patients reported doing yoga.32 Evidence from other investigations using the I-CAM-Q revealed yoga was practised by 9% of cancer patients in Germany,88 5.9% of patients in Portugal,69 5% of patients in Canada,70 27.9% of patients in Norway71 and 32.1% of patients in Poland.89 The most popular reason why cancer patients did yoga was to improve overall well-being.71,89 Research focusing on mind–body practices suggests yoga can reduce anxiety, stress and depression in people with cancer, as well as reduce fatigue in breast cancer survivors and those with early-stage breast cancer.90

Disclosure of traditional and complementary medicine to physicians

This study successfully evaluated the proportion of cancer patient who disclosed T&CM use to their physicians and the most common reasons for nondisclosure. It was found that only one-third of T&CM users informed their physician about T&CM use. The two main reasons why cancer patients did not tell their doctor about T&CM was either because their doctor did not ask, or the patient believed their doctor did not need to know. Systematic reviews conducted found that nondisclosure of T&CM use to healthcare providers is common, with popular reasons being that physicians do not ask patients, cancer patients assume T&CM does not affect conventional therapy, patients suppose it is not important for their physicians to know, patients fear their specialists’ reaction, and patients think physicians lack knowledge of or are unwelcoming to T&CM use.33,92 From this, it can be deduced that not enough physicians are asking their patients about T&CM use and not enough patients are aware of the potential harm T&CM products may cause if combined with anticancer treatment. In this study, only a few cancer patients reported being afraid to tell their doctor, implying many patients share good relationships with and trust their doctors. The T&CM disclosure rate of this study conducted in KwaZulu-Natal was found to be higher than patient disclosure in Accra (Ghana),29 Gondar (Ethiopia),30 Sokoto (Nigeria),93 Engu (Nigeria),37 Moshi (Tanzania)38 and Marrakech (Morocco).39

Disclosure of T&CM is also important as many patients obtain T&CM products without specialist consultation. In this study, 27% of participants used at least one type of herbal product, while only 8% saw a herbalist. Similarly, nine participants used a homeopathic remedy, while eight participants visited a homeopath. Findings from other studies using the I-CAM-Q revealed a similar trend. For example, a German study showed 33% of participants used herbal medicine, while 23% had seen a herbalist, and 17% used a homeopathic remedy compared to only 3% who consulted a homeopath.88 In Poland, 84.7% of cancer patients used herbal medicine, yet only 27.3% visited a herbalist, and 19.1% used homeopathic remedies, while 15.1% saw a homeopath.89 Among Portuguese cancer patients, 37.3% reported using natural products and only 9.8% consulted a herbalist.69 These comparisons suggest that the use of herbal and homeopathic products frequently occurs independently of specialist consultation. This highlights how T&CM products are often perceived as accessible, self-initiated treatment options rather than practitioner-led interventions requiring counselling and underscores the perception that ‘natural’ products are safe.

Conventional healthcare providers sought by cancer patients

Physicians were the most frequently visited healthcare provider, and more than 80% of cancer patients who saw a physician found them very helpful. Physicians refer to registered medical practitioners who obtained a degree in medicine, specialising in the diagnosis and treatment of diseases.35 In South Africa, physicians are known to have an important role in cancer care, ranging from primary care to specialised oncology and palliative care. The South African health system makes every effort to be in close contact with the community; thus physicians are involved from the early detection and treatment of cancer to survivorship and helping patients cope with psychosocial burdens linked to cancer.94

A study conducted in 2018 in KwaZulu-Natal, South Africa, found that a one-way referral system of cancer patients existed where only traditional healthcare practitioners refer patients to mainstream hospitals so a confirmed diagnosis can be reached prior to the initiation of conventional treatment.95 Despite the South African government’s directive for collaboration with traditional healthcare practitioners, mainstream doctors were not referring patients to traditional practitioners due to the absence of guidelines for referral and lack of scientific evidence supporting traditional therapies.95

The second most commonly visited healthcare provider was physiotherapists. Physiotherapy also forms part of mainstream medicine and involves using physical methods to promote healing.35 From a study conducted in South Africa among physiotherapists, it was found that many participants regularly treated cancer patients.96 Chemotherapy-induced peripheral neuropathy is a common, persistent side effect of chemotherapy that impairs daily functioning and quality of life, sometimes lasting up to 6 months after treatment.97 When occurring during chemotherapy, it may necessitate dose reduction or discontinuation, adversely affecting cancer management.97 Physiotherapists play an important role in managing such side effects as well as assisting patients in improving their functional ability, exercise capacity, lymphedema management and overall quality of life, while also reducing hospital stay and postoperative recovery time.98

From the responses obtained in this study, patients sought general practitioners and physiotherapists for health problems both related and not related to cancer. These results suggest that mainstream medical treatment in KwaZulu-Natal is still most relied on in the private sector; additionally, less than half of the participants surveyed were interested in learning more about T&CM therapies.

Limitations

This cross-sectional study solely focused on cancer patients attending oncology centres within the private healthcare sector receiving conventional mainstream treatment in one South African province. The private healthcare sector was selected based on the premise that cancer patients in this setting were more likely to have the funds to access and afford T&CM. In South Africa, since T&CM is not subsidised by the government, T&CM is paid for out-of-pocket, and patients in the private sector are assumed to have higher income levels and thus more funds to utilise on such therapies. Studying this sample group enables initial exploration of T&CM among cancer patients with fewer financial barriers, with the hope of identifying and exploring patterns of T&CM use. However, this introduces several limitations.

To begin with cancer patients within the public healthcare system and those directly consulting with T&CM practitioners were not included in the study. As a result, the study may over-represent cancer patients with higher income levels and access to private conventional medical care, therefore possibly skewing the results towards higher use and trust in conventional medicine. Additionally, only focusing on patients in the private sector with greater access to alternative therapies and the financial means to try various types of T&CM can misrepresent a population of the region that cannot access or afford T&CM.

Since all cancer patients surveyed were already in a conventional healthcare setting, their views and treatment choices may not reflect those of individuals who rely solely on public healthcare or T&CM. As a result, the findings cannot be extrapolated to the broader cancer patient population in South Africa, where there is a wide variation in cultural practices and access to healthcare.

Furthermore, the relatively small sample size may restrict the reality of the target population and decrease the statistical power required to detect significant predictors of T&CM use. This could be a possible reason why no strong associations could be found between demographic variables and T&CM use. Additionally, this study’s sample does not entirely represent the broader South African population in terms of demographics. National population estimates for South Africa in 2025 indicate a racial distribution of 82% African people, 8.5% coloured people, 7.2% white people and 2.6% Indian people.99 In contrast, this cross-sectional study had a noticeably different racial composition of 15% African people, 14% coloured people, 24% white people and 47% Indian people. National statistics indicate that 84% of South Africans have attained secondary or tertiary education,100 whereas this study reported a slightly higher proportion, with 89% of participants achieving this level of education. With respect to employment status, statistics from September 2025 indicate that 40.7% of the South African population is employed, 31.9% is unemployed, and approximately 10.5% is retired.101 In comparison, this study sample demonstrated a distribution in which 67% of participants were employed, 10% were unemployed, and 23% were retired. These deviations from the national demographic profile represent a limitation of the study, as the sample is not fully representative of South Africa’s overall population.

Future studies should be conducted in different provinces and aimed at including more diverse patient groups, particularly those within the public healthcare sector and those using T&CM as a primary source of healthcare, in order to yield a more comprehensive and inclusive picture of health-seeking behaviour among cancer patients in South Africa.

Conclusion

The cross-sectional study shed light on the prevalence of T&CM use among cancer patients attending private cancer centres in KwaZulu-Natal. While conventional medicine stands as the country’s primary and main approach for managing cancer, a significant number of cancer patients use forms of T&CM concurrently. This study revealed that a large portion of these patients do not disclose T&CM use to their physicians. This gap in communication highlights the need for increased awareness and proactive engagement by healthcare providers, especially during chemotherapy, where potentially harmful interactions with complementary treatment may occur.

The findings of this study emphasise the growing need for structured, evidence-based integration of T&CM into South Africa’s healthcare system. Although the establishment of the Interim Traditional Health Practitioners Council in 2013 marked an important step towards regulating practitioner registration and ensuring ethical and safety standards, the absence of comprehensive policies and clinical guidelines continues to limit the safe incorporation of T&CM into mainstream oncology treatment. Strengthening this integration requires rigorous research on the mechanisms of action, safety, efficacy and potential interactions of commonly used therapies, alongside improved training that equips healthcare providers to engage in open, non-judgemental conversations with patients about T&CM use.

The WHO TCIM Strategy provides a valuable framework to support these national efforts. By emphasising the need for stronger scientific evidence and effective regulatory systems, the strategy aligns closely with the study’s call for rigorous evidence-based research and clearer clinical guidance. Its commitment to promoting universal access to safe, effective and patient-centred TCIM offers a strategic pathway for South Africa to advance towards a more integrated, culturally sensitive and patient-focused cancer care system. Collectively, these efforts can enhance policy development, improve clinical decision-making and ultimately contribute to holistic healthcare for cancer patients.

Acknowledgements

Heartfelt thanks to all individuals who participated and assisted in this research study, including the private hospital groups that granted permission to conduct the study on their premises.

This article includes content that overlaps with research originally conducted as part of Ammaarah Sheik Adam’s master’s thesis titled ‘The use of traditional and complementary medicine among cancer patients’, submitted to the Department of Pharmaceutical Sciences, University of KwaZulu-Natal in 2025. The thesis was supervised by Prof. Frasia Oosthuizen and Prof. Varsha Bangalee. Portions of the introduction and discussion have been revised, updated and adapted for journal publication. The original thesis is not publicly available at present.

This article is based on data from a larger study. A related article focusing on summarising T&CM use among cancer patients in sub-Saharan Africa, specifically the types of T&CM used, reasons for use, patient satisfaction and patient disclosure of T&CM use to physicians, has been published in Health SA Gesondheid, 29, Article 2743 (https://hsag.co.za/index.php/hsag/article/view/2743/5343). The present article addresses a distinct research question, focusing on the types of T&CM used by cancer patients in one province of South Africa, their reasons for use, how helpful they find T&CM and whether they disclosed T&CM use to their physicians.

Competing interests

The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.

CRediT authorship contribution

Ammaarah Sheik Adam: Conceptualisation, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualisation, Writing – original draft and Writing – review & editing. Frasia Oosthuizen: Conceptualisation, Methodology, Project administration, Supervision, Validation, Visualisation and Writing – review & editing. Varsha Bangalee: Conceptualisation, Methodology, Project administration, Supervision, Validation, Visualisation and Writing – review & editing. All authors reviewed the article, contributed to the discussion of results, approved the final version for submission and publication, and take responsibility for the integrity of its findings.

Funding information

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Data availability

The raw data (completed questionnaires) are held by the corresponding author. The electronic data (data abstracted from questionnaires) are stored on the researcher’s hard disk drive and may only be available upon reasonable request from the corresponding author, Ammaarah Sheik Adam.

Disclaimer

The views and opinions expressed in this article are those of the authors and are the product of professional research. It does not necessarily reflect the official policy or position of any affiliated institution, funder, agency or that of the publisher. The authors are responsible for this article’s results, findings and content.

References

  1. Adams C. How to improve access to cancer medicines in low and middle-income countries. World Economic Forum [homepage on the Internet]. 2022 [cited 2026 Jun 01]. Available from: https://www.weforum.org/agenda/2022/04/imrpove-access-cancer-medicines/.
  2. World Health Organization. WHO global report on traditional and complementary medicine 2019. Geneva: World Health Organization; 2019.
  3. World Health Organization. Global traditional medicine strategy 2025–2034. Geneva: World Health Organization; 2025.
  4. Flatie T, Gedif T, Asres K, Gebre-Mariam T. Ethnomedical survey of Berta ethnic group Assosa Zone, Benishangul-Gumuz regional state, mid-west Ethiopia. J Ethnobiol Ethnomed. 2009;5(1):14. https://doi.org/10.1186/1746-4269-5-14
  5. Gari A, Yarlagadda R, Wolde-Mariam M. Knowledge, attitude, practice, and management of traditional medicine among people of Burka Jato Kebele, West Ethiopia. J Pharm Bioallied Sci. 2015;7(2):136–144. https://doi.org/10.4103/0975-7406.148782
  6. Nsagha DS, Ayima CW, Nana-Njamen T, Assob JCN. The role of traditional, complementary/alternative medicine in primary healthcare, adjunct to universal health coverage in Cameroon: A review of the literature. Am J Epidemiol Infect Dis. 2020;8(1):37–47.
  7. Zhang Q. Traditional and complementary medicine in primary health care. In: Medcalf A, Bhattacharya S, Momen H, et al., editors. Health for all: The journey of universal health coverage [homepage on the Internet]. Hyderabad: Orient Blackswan; 2015 [cited 2026 Apr 24]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK316267/
  8. Malangu N. Self-reported use of traditional, complementary and over-the-counter medicines by HIV-infected patients on antiretroviral therapy in Pretoria, South Africa. Afr J Tradit Complement Altern Med. 2007;4(3):273–278. https://doi.org/10.4314/ajtcam.v4i3.31219
  9. Hughes GD, Aboyade OM, Clark BL, Puoane TR. The prevalence of traditional herbal medicine use among hypertensives living in South African communities. BMC Complement Altern Med. 2013;13(1):38. https://doi.org/10.1186/1472-6882-13-38
  10. Chetty L, Govender N, Reddy P. Traditional medicine use among type 2 diabetes patients in KZN. Adv Public Health. 2022;2022:7334080. https://doi.org/10.1155/2022/7334080
  11. Peltzer K. Utilization and practice of traditional/complementary/alternative medicine (TM/CAM) in South Africa. Afr J Tradit Complement Altern Med [serial online]. 2009 [cited 2026 Apr 29];6(2):175–185. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816568/
  12. Van Staden AM, Joubert GB. Interest in and willingness to use complementary, alternative and traditional medicine among academic and administrative university staff in Bloemfontein, South Africa. Afr J Tradit Complement Altern Med. 2014;11(5):61–66. https://doi.org/10.4314/ajtcam.v11i5.10
  13. Peltzer K, Pengpid S. Prevalence and determinants of traditional, complementary and alternative medicine provider use among adults from 32 countries. Chin J Integr Med. 2018;24(8):584–590. https://doi.org/10.1007/s11655-016-2748-y
  14. Booth Z. South Africa’s traditional medicines should be used in modern health care [homepage on the Internet]. The Conversation; 2023 [cited 2025 Jul 10]. Available from: https://theconversation.com/south-africas-traditional-medicines-should-be-used-in-modern-health-care-211382
  15. Booth Z. 2023-08 – Traditional medicines should be used in healthcare – Wits University [homepage on the Internet]. Johannesburg: Wits University; 2023 [cited 2026 Jan 07]. Available from: https://www.wits.ac.za/news/latest-news/opinion/2023/2023-08/traditional-medicines-should-be-used-in-healthcare.html
  16. Cumes D. South African indigenous healing: How it works. Explore (NY). 2013;9(1):58–65. https://doi.org/10.1016/j.explore.2012.11.007
  17. Mothibe ME, Sibanda M. African traditional medicine: South African perspective. In: Mordeniz C, editor. Traditional and complementary medicine. London: IntechOpen, 2019; p. 6–13.
  18. Vawda N. The National Health Insurance and traditional healing in South Africa. New Agenda S Afr J Soc Econ Policy. 2017;2017(67):35–38.
  19. Hughes GD, Aboyade OM, Okonji OC, et al. Cost of traditional herbal medicines for noncommunicable diseases in rural and urban communities in South Africa. Value Health Reg Issues. 2022;29:66–75. https://doi.org/10.1016/j.vhri.2021.08.006
  20. James PB, Wardle J, Steel A, Adams J. Traditional, complementary and alternative medicine use in sub-Saharan Africa: A systematic review. BMJ Glob Health. 2018;3(5):e000895. https://doi.org/10.1136/bmjgh-2018-000895
  21. Vasques AC, Sr, Cavaco P, Duarte T, et al. The use of herbal medicines among cancer patients. Cureus. 2024;16(2):e53455. https://doi.org/10.7759/cureus.53455
  22. Creative Research Systems. Sample size calculator [homepage on the Internet]. Creative Research Systems; 2003 [cited 2023 Mar 06]. Available from: https://www.surveysystem.com/sscalc.htm
  23. Quandt SA, Verhoef MJ, Arcury TA, et al. Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). J Altern Complement Med. 2009;15(4):331–339. https://doi.org/10.1089/acm.2008.0521
  24. South African Health Products Regulatory Authority (SAHPRA). Complementary medicines – Health supplements safety and efficacy [homepage on the Internet]. Pretoria: SAHPRA; 2022 [cited 2025 Jul 10]. Available from: https://www.sahpra.org.za/wp-content/uploads/2022/03/7.04_CM_SE_Health_Supplements_Mar22_v4_3.pdf
  25. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499. https://doi.org/10.1016/j.ijsu.2014.07.013
  26. Keene MR, Heslop IM, Sabesan SS, Glass BD. Complementary and alternative medicine use in cancer: A systematic review. Complement Ther Clin Pract. 2019;35:33–47. https://doi.org/10.1016/j.ctcp.2019.01.004
  27. Hill J, Mills C, Li Q, Smith JS. Prevalence of traditional, complementary, and alternative medicine use by cancer patients in low income and lower-middle income countries. Glob Public Health. 2019;14(3):418–430. https://doi.org/10.1080/17441692.2018.1534254
  28. Van Heerden I. The evaluation and risk assessment of complementary medicine use by cancer patients treated at an academic hospital in Johannesburg [MSc dissertation] [homepage on the Internet]. Johannesburg: University of the Witwatersrand; 2024 [cited 2026 Jan 07]. Available from: https://wiredspace.wits.ac.za/handle/10539/46900
  29. Yarney J, Donkor A, Opoku SY, et al. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: A cross-sectional study. BMC Complement Altern Med. 2013;13(1):16. https://doi.org/10.1186/1472-6882-13-16
  30. Erku DA. Complementary and alternative medicine use and its association with quality of life among cancer patients receiving chemotherapy in Ethiopia: A cross-sectional study. Evid Based Complement Alternat Med. 2016;2016:2809875. https://doi.org/10.1155/2016/2809875
  31. Hill J, Seguin R, Manda A, et al. Prevalence of traditional, complementary, and alternative medicine (TCAM) among adult cancer patients in Malawi. Cancer Causes Control. 2022;33(8):1047–1057. https://doi.org/10.1007/s10552-022-01563-0
  32. Kiwanuka F. Complementary and alternative medicine use: Influence of patients’ satisfaction with medical treatment among breast cancer patients at Uganda Cancer Institute. Adv Biosci Clin Med. 2018;6(1):24–29. https://doi.org/10.7575/aiac.abcmed.v.6n.1p.24
  33. Alsharif F. Discovering the use of complementary and alternative medicine in oncology patients: A systematic literature review. Evid Based Complement Alternat Med. 2021;2021:6619243. https://doi.org/10.1155/2021/6619243
  34. Jimoh AO, Hudu SA, Aliyu UM, et al. Exploring the use of complementary and alternative medicine among cancer patients in Africa: A systematic review. Sci Afr. 2025;29:e02852. https://doi.org/10.1016/j.sciaf.2025.e02852
  35. Law J, Martin E, editors. Concise medical dictionary. 10th ed. Oxford: Oxford University Press; 2020.
  36. Olsson R. Using vitamins and supplements during cancer therapy [homepage on the Internet]. Phoenix (AZ): Banner Health; 2023 [cited 2025 Jul 10]. Available from: https://www.bannerhealth.com/healthcareblog/teach-me/vitamin-supplements-and-cancer-therapy
  37. Ajah LO, Ifezuoke DT, Ajah MI, et al. Complementary and alternative medicine use among gynaecological cancer patients in Enugu, South-East Nigeria. Glob J Health Sci. 2021;13(9):16–23. https://doi.org/10.5539/gjhs.v13n9p16
  38. Henke O, Bruchhausen W, Massawe A. Use of herbal medicine is associated with late-stage presentation in Tanzanian patients with cancer: A survey to assess the utilization of and reasons for the use of herbal medicine. JCO Glob Oncol. 2022;8:e2200069. https://doi.org/10.1200/GO.22.00069
  39. Tazi I, Nafil H, Sifesalam M, Bouchtia M, Mahmal L. Prevalence of complementary and alternative medicine use in patients with hematological malignancies in Marrakech, Morocco. J Acupunct Meridian Stud. 2013;6(2):67–68. https://doi.org/10.1016/j.jams.2012.12.007
  40. Ong’udi M, Mutai P, Weru I. Study of the use of complementary and alternative medicine by cancer patients at Kenyatta National Hospital, Nairobi, Kenya. J Oncol Pharm Pract. 2019;25(4):918–928. https://doi.org/10.1177/1078155218805543
  41. Asiimwe JB, Nagendrappa PB, Atukunda EC, Malinga GM, Bukirwa J. Prevalence of herbal medicine use among cancer patients: A systematic review and meta-analysis. BMC Complement Med Ther. 2021;21:248. https://doi.org/10.1155/2021/9963038
  42. Paikra BK, Dhongade HKJ, Gidwani B. Phytochemistry and pharmacology of Moringa oleifera Lam. J Pharmacopuncture. 2017;20(3):194–200. https://doi.org/10.3831/KPI.2017.20.022
  43. Zunica ERM, Yang S, Coulter A, White C, Kirwan JP, Gilmore LA. Moringa oleifera seed extract concomitantly supplemented with chemotherapy worsens tumor progression in mice with triple negative breast cancer and obesity. Nutrients. 2021;13(9):2923. https://doi.org/10.3390/nu13092923
  44. Amoo SO, Aremu AO, Van Staden J. Unraveling the medicinal potential of South African Aloe species. J Ethnopharmacol. 2014;153(1):19–41. https://doi.org/10.1016/j.jep.2014.01.036
  45. Chiu CC, Hsiao YW, Wen YC, Chang TY, Chen SH, Jaing TH. Aloe vera gel for prevention of chemotherapy-induced hyperpigmentation: Four case reports. Medicine (Baltimore). 2023;102(25):e34037. https://doi.org/10.1097/MD.0000000000034037
  46. Majdalawieh AF, Massri M, Nasrallah GK. A comprehensive review on the anti-cancer properties and mechanisms of action of sesamin, a lignan in sesame seeds (Sesamum indicum). Eur J Pharmacol. 2017;815:512–521. https://doi.org/10.1016/j.ejphar.2017.10.020
  47. Imran S, Munir S, Altemimi AB, et al. Therapeutic implications of flaxseed peptides and bioactive components against various diseases. J Funct Foods. 2024;119:106324. https://doi.org/10.1016/j.jff.2024.106324
  48. Mokhtarian R, Rajabi S, Zahedian S, Jafarinejad-Farsangi S, Hadizadeh M, Sadeghinejad M. The effect of saffron and its extracts on the treatment of breast cancer: A narrative review. Ann Pharm Fr. 2024;82(4):629–640. https://doi.org/10.1016/j.pharma.2024.02.011
  49. Alalyu RS. The effect of medicinal plants fennel seeds, and olive leaves to inhibit growth on lung, leukemia, and colon cell lines [MSc dissertation] [homepage on the Internet]. Nashville, TN: Tennessee State University; 2016 [cited 2024 Nov 10]. Available from: https://digitalscholarship.tnstate.edu/dissertations/AAI10158637
  50. Kaefer CM, Milner JA. Herbs and spices in cancer prevention and treatment. In: Benzie IFF, Wachtel-Galor S, editors. Herbal medicine: Biomolecular and clinical aspects [homepage on the Internet]. 2nd ed. Boca Raton, FL: CRC Press; 2011 [cited 2024 Nov 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK92773/
  51. Chen X-W, Sneed KB, Pan S-Y, et al. Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab. 2012;13(5):640–651. https://doi.org/10.2174/1389200211209050640
  52. Liu C, Liu S, Wang Y, et al. A comprehensive overview of acupuncture therapy over the past 20 years: Machine learning-based bibliometric analysis. Complement Ther Med. 2025;88:103110. https://doi.org/10.1016/j.ctim.2024.103110
  53. Öztekin C, Öztekin A. Global trends in acupuncture research: A scientometric analysis from 1980 to 2023. Medicine (Baltimore). 2024;103(36):e39549. https://doi.org/10.1097/MD.0000000000039549
  54. Wu X, Chung VCH, Hui EP, et al. Effectiveness of acupuncture and related therapies for palliative care of cancer: Overview of systematic reviews. Sci Rep. 2015;5(1):16776. https://doi.org/10.1038/srep16776
  55. Lawrence DJ, Meeker WC. Chiropractic and CAM utilization: A descriptive review. Chiropr Osteopat. 2007;15(1):2. https://doi.org/10.1186/1746-1340-15-2
  56. National Cancer Institute. Chiropractic therapy [homepage on the Internet]. Bethesda, MD: NCI; 2011 [cited 2025 Jul 10]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chiropractic-therapy
  57. Laoudikou MT, McCarthy PW. Patients with cancer. Is there a role for chiropractic? J Can Chiropr Assoc. 2020;64(1):32–42.
  58. Naidoo S, Hoenselaar NK, Yelverton C. Chiropractic attitude and utilisation of evidence-based practice in South Africa: A secondary analysis. Chiropr Man Therap. 2024;32(1):13. https://doi.org/10.1186/s12998-024-00534-3
  59. Johnson T, Boon H. Where does homeopathy fit in pharmacy practice? Am J Pharm Educ. 2007;71(1):7. https://doi.org/10.5688/aj710107
  60. Relton C, Cooper K, Viksveen P, Fibert P, Thomas K. Prevalence of homeopathy use by the general population worldwide: A systematic review. Homeopathy. 2017;106(2):69–78. https://doi.org/10.1016/j.homp.2017.03.002
  61. Erwin K, Marks MM, Couchman I. Homeopathic health care in a low-income housing estate in Durban: Possibilities for a plural health care model in South Africa. Int J Health Wellness Soc. 2014;3(3):1–16. https://doi.org/10.18848/2156-8960/CGP/v03i03/41041
  62. Joubert KS, George BP, Razlog R, Abrahamse H. A review of preclinical research on the effects of photodynamic therapy and homeopathic medicine on cancer cells. Altern Ther Health Med. 2021;27(6):40–50.
  63. Anjani K. A re-evaluation of castor (Ricinus communis L.) as a crop plant. Perspect Agric Vet Sci Nutr Nat Resour. 2014;9(1):1–21. https://doi.org/10.1079/PAVSNNR20149038
  64. Gubili J, Weinstein A, Nien Y. What the evidence says about castor oil in patients with cancer [homepage on the Internet]. Oncology Nursing Society. 2025 [cited 2024 Nov 15]. Available from: https://www.ons.org/publications-research/voice/news-views/01-2025/what-evidence-says-about-castor-oil-patients-cancer
  65. Potter GA, Burke MD. Salvestrols–natural products with tumour selective activity. J Orthomol Med. 2006;21(1):34–36.
  66. Zoi V, Galani V, Lianos GD, Voulgaris S, Kyritsis AP, Alexiou GA. The role of curcumin in cancer treatment. Biomedicines. 2021;9(9):1086. https://doi.org/10.3390/biomedicines9091086
  67. Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O. Phytochemicals in cancer treatment: From preclinical studies to clinical practice. Front Pharmacol. 2020;10:1614. https://doi.org/10.3389/fphar.2019.01614
  68. Kumar P, Sulakhiya K, Barua CC, Mundhe N. TNF-α, IL-6 and IL-10 expressions, responsible for disparity in action of curcumin against cisplatin-induced nephrotoxicity in rats. Mol Cell Biochem. 2017;431(1):113–122. https://doi.org/10.1007/s11010-017-2981-5
  69. Vidal M, Carvalho C, Bispo R. Use of complementary and alternative medicine in a sample of women with breast cancer. SAGE Open. 2013;3(2):2158244013502497. https://doi.org/10.1177/2158244013502497
  70. Buckner CA, Lafrenie RM, Dénommée JA, Caswell JM, Want DA. Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr Oncol. 2018;25(4):275–281. https://doi.org/10.3747/co.25.3884
  71. Kristoffersen AE, Nilsen JV, Stub T, et al. Use of complementary and alternative medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway. BMC Complement Med Ther. 2022;22(1):202. https://doi.org/10.1186/s12906-022-03606-0
  72. Steel A, Tricou C, Monsarrat T, et al. The perceptions and experiences of osteopathic treatment among cancer patients in palliative care: A qualitative study. Support Care Cancer. 2018;26(10):3627–3633. https://doi.org/10.1007/s00520-018-4233-y
  73. Roberts A, Harris K, Outen B, et al. Osteopathic manipulative medicine: A brief review of the hands-on treatment approaches and their therapeutic uses. Medicines (Basel). 2022;9(5):33. https://doi.org/10.3390/medicines9050033
  74. Rolle G, Tremolizzo L, Somalvico F, Ferrarese C, Bressan LC. Pilot trial of osteopathic manipulative therapy for patients with frequent episodic tension-type headache. J Am Osteopath Assoc. 2014;114(9):678–685. https://doi.org/10.7556/jaoa.2014.136
  75. Goldstein FJ, Jeck S, Nicholas AS, Berman MJ, Lerario M. Preoperative intravenous morphine sulfate with postoperative osteopathic manipulative treatment reduces patient analgesic use after total abdominal hysterectomy. J Am Osteopath Assoc. 2005;105(6):273–279.
  76. Belvaux A, Bouchoucha M, Benamouzig R. Osteopathic management of chronic constipation in women patients. Results of a pilot study. Clin Res Hepatol Gastroenterol. 2017;41(5):602–611. https://doi.org/10.1016/j.clinre.2016.12.003
  77. Zadro S, Stapleton P. Awareness and use of Reiki, Reiki research, energy healing, and complementary medicine amongst Australian health professionals and the community. Glob Adv Integr Med Health. 2026;15:27536130261434249. https://doi.org/10.1177/27536130261434249
  78. Reiki Association of South Africa. Home [homepage on the Internet]. Reiki Association of South Africa; 2024 [cited 2025 Aug 04]. Available from: https://reikiassociation.co.za/
  79. Fleisher KA, Mackenzie ER, Frankel ES, Seluzicki C, Casarett D, Mao JJ. Integrative Reiki for cancer patients: A program evaluation. Integr Cancer Ther. 2014;13(1):62–67. https://doi.org/10.1177/1534735413503547
  80. Jones J, Thomson P, Lauder W, Howie K, Leslie SJ. Reflexology has an acute (immediate) haemodynamic effect in healthy volunteers: A double-blind randomised controlled trial. Complement Ther Clin Pract. 2012;18(4):204–211. https://doi.org/10.1016/j.ctcp.2012.03.006
  81. Stephenson NLN, Weinrich SP, Tavakoli AS. The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer. Oncol Nurs Forum. 2000;27(1):67–72.
  82. Özdelikara A, Tan M. The effect of reflexology on the quality of life with breast cancer patients. Complement Ther Clin Pract. 2017;29:122–129. https://doi.org/10.1016/j.ctcp.2017.09.004
  83. Hurley-Browning L. Self care during cancer [homepage on the Internet]. Philadelphia, PA: Penn Medicine; 2018 [cited 2025 Jul 10]. Available from: https://www.pennmedicine.org/cancer/about/focus-on-cancer/2018/october/self-care-during-cancer
  84. Chui PL, Abdullah KL, Wong LP, Taib NA. Prayer-for-health and complementary alternative medicine use among Malaysian breast cancer patients during chemotherapy. BMC Complement Altern Med. 2014;14(1):425. https://doi.org/10.1186/1472-6882-14-425
  85. Peltzer K, Friend-du Preez N, Ramlagan S, Fomundam H. Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2008;8(1):255. https://doi.org/10.1186/1471-2458-8-255
  86. Paul A, Kalir T. The role of spirituality/religiosity in the cancer journey. Med Res Arch. 2025;13(3):1–11. https://doi.org/10.18103/mra.v13i3.6318
  87. Astrow AB, Kwok G, Sharma RK, Fromer N, Sulmasy DP. Spiritual needs and perception of quality of care and satisfaction with care in hematology/medical oncology patients: A multicultural assessment. J Pain Symptom Manage. 2018;55(1):56–64.e1. https://doi.org/10.1016/j.jpainsymman.2017.08.009
  88. Re ML, Schmidt S, Güthlin C. Translation and adaptation of an international questionnaire to measure usage of complementary and alternative medicine (I-CAM-G). BMC Complement Altern Med. 2012;12(1):259. https://doi.org/10.1186/1472-6882-12-259
  89. Jędrzejewska AB, Ślusarska BJ, Jurek K, Nowicki GJ. Translation and cross-cultural adaptation of the international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q) into polish and cross-sectional study. Int J Environ Res Public Health. 2023;20(1):124. https://doi.org/10.3390/ijerph20010124
  90. National Center for Complementary and Integrative Health. Cancer and complementary health approaches: What you need to know [homepage on the Internet]. Bethesda, MD: National Center for Complementary and Integrative Health; 2017 [cited 2026 Jan 05]. Available from: https://www.nccih.nih.gov/health/cancer/complementary-integrative-research
  91. Jose D, Cacodcar JA. Effectiveness of a relaxation technique on reducing anxiety, depression, and fatigue among women with breast cancer in Goa: A randomized controlled trial [homepage on the Internet]. Bambolim (Goa, India): medRxiv; 2025 [cited 2026 Jan 05]. Available from: https://doi.org/10.64898/2025.12.17.25342348
  92. Akeeb AA, King SM, Olaku O, White JD. Communication between cancer patients and physicians about complementary and alternative medicine: A systematic review. J Integr Complement Med. 2023;29(2):80–98. https://doi.org/10.1089/jicm.2022.0516
  93. Aliyu UM, Awosan KJ, Oche MO, Taiwo AO, Jimoh AO, Okuofo EC. Prevalence and correlates of complementary and alternative medicine use among cancer patients in Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria. Niger J Clin Pract. 2017;20(12):1576–1583. https://doi.org/10.4103/njcp.njcp_88_17
  94. Ras T, Adeleke O, Moodley J. The role of primary care practitioners in cancer control in South Africa: A systems-based case study. S Afr Health Rev. 2024;26(10):119020. https://doi.org/10.61473/001c.119020
  95. Nkosi PB, Sibiya MN. Perceptions of traditional health practitioners and radiation oncologists regarding referral of cancer patients in a cooperative practice in KwaZulu-Natal province, South Africa. Int J Afr Nurs Sci. 2018;8:117–121. https://doi.org/10.1016/j.ijans.2018.04.003
  96. Niemand EA, Cochrane ME, Eksteen CA. Physiotherapy management of chemotherapy-induced peripheral neuropathy in Pretoria, South Africa. S Afr J Physiother. 2020;76(1):1482. https://doi.org/10.4102/sajp.v76i1.1482
  97. Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155(12):2461–2470. https://doi.org/10.1016/j.pain.2014.09.020
  98. Bernardo-Filho M, Barbosa Junior ML, Da Cunha Sá-Caputo D, et al. The relevance of the procedures related to the physiotherapy in the interventions in patients with prostate cancer: Short review with practice approach. Int J Biomed Sci. 2014;10(2):73–84. https://doi.org/10.59566/IJBS.2014.10073
  99. Statistics South Africa. Inside the numbers: SA population trends for 2025 [homepage on the Internet]. Pretoria: Statistics South Africa; 2025 [cited 2025 Dec 04]. Available from: https://www.statssa.gov.za/?p=18613
  100. Afrobarometer. AD970: South Africans give mixed reviews on government’s performance on education [homepage on the Internet]. 2025 [cited 2025 Dec 04]. Available from: https://www.afrobarometer.org/publication/ad970-south-africans-give-mixed-reviews-on-governments-performance-on-education/
  101. Trading Economics. South Africa employment rate: 2000–2019 data, 2025 forecast [homepage on the Internet]. 2025 [cited 2025 Dec 04]. Available from: https://tradingeconomics.com/south-africa/employment-rate


Crossref Citations

No related citations found.